George A. Fisher Jr.

Back to Profile

Publication Details

  • Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancer.

    Kuo T, Cho CD, Halsey J, Wakelee HA, Advani RH, Ford JM, Fisher GA, Sikic BI. J Clin Oncol. 2005; 23 (24): 5613-9

    To investigate the gefitinib, fluorouracil (FU), leucovorin, and oxaliplatin regimen (IFOX) in previously treated patients with metastatic colorectal cancer.

    PubMedID: 16110021

Stanford Medicine Resources:

Footer Links: